Cardiovascular disease prevention in primary care

被引:7
|
作者
Chauhan, Umesh [1 ]
机构
[1] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England
关键词
communication; CVD risk assessment; management and surveillance;
D O I
10.1093/bmb/ldm002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the publication of the National Service Framework for coronary heart disease, there has been a move towards primary disease prevention with a greater focus on an individual's absolute risk. Meta-analysis and systematic reviews of the evidence for primary prevention are incomplete and the current guidelines and policy have led to considerable confusion in clinical practice. There is an increased use of risk assessment tools but no effective method of reviewing current activity with the limited integration into the existing Quality Outcome Framework. There is an inadequate evidence for some of the risk factors used to identify individuals at risk, the risk calculators used to quantify the degree of risk and the methods of communicating risk to patients are largely unproven or completely missing. There is a need for a co-ordinated vascular disease prevention programme which can be applied at the individual and at the population level but is also amenable to evaluation.
引用
收藏
页码:65 / 79
页数:15
相关论文
共 50 条
  • [31] Statins for primary prevention of cardiovascular disease
    Otto, Catherine M.
    HEART, 2017, 103 (07) : 477 - 478
  • [32] Statins for primary prevention of cardiovascular disease
    French, Louise
    AUSTRALIAN PRESCRIBER, 2012, 35 (03) : 77 - 77
  • [33] Aspirin for primary prevention of cardiovascular disease
    Waltering, A
    Hemkens, L
    Florack, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (49) : 2847 - 2852
  • [34] Yoga for the primary prevention of cardiovascular disease
    Hartley, Louise
    Dyakova, Mariana
    Holmes, Jennifer
    Clarke, Aileen
    Lee, Myeong Soo
    Ernst, Edzard
    Rees, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
  • [35] Statins for primary prevention of cardiovascular disease
    Otto, Catherine M.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
  • [36] Aspirin for primary prevention of cardiovascular disease
    Gelbenegger, G.
    Postula, M.
    Pecen, L.
    Halvorsen, S.
    Lesiak, M.
    Schoergenhofer, C.
    Jilma, B.
    Hengstenberg, C.
    Siller-Matula, J. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 276 - 276
  • [37] Primary prevention strategies for cardiovascular disease
    Tyerman, G
    Tyerman, P
    Roscoe, TJ
    BRITISH MEDICAL JOURNAL, 2002, 325 (7370): : 969 - 969
  • [38] Polypills for primary prevention of cardiovascular disease
    Clara K. Chow
    Qingtao Meng
    Nature Reviews Cardiology, 2019, 16 : 602 - 611
  • [39] Aspirin in the primary prevention of cardiovascular disease
    Galloway, Colin F.
    Stevenson, John C.
    MATURITAS, 2011, 68 (01) : 3 - 4
  • [40] HRT and the primary prevention of cardiovascular disease
    Stevenson, John C.
    MATURITAS, 2007, 57 (01) : 31 - 34